Wednesday, July 25, 2018 10AM PDT | 1PM EDT | 6PM BST | 7PM CEST Checkpoint inhibitors have opened new avenues for treating cancer, however patients treated with these drugs often show poor durability or responsiveness to treatment, and immune toxicity...
Read More »